States Explore Adding Female Orgasm Disorder as Medical Cannabis Condition
Advocates are pushing to include Female Orgasmic Disorder (FOD) as a qualifying condition for medical cannabis in six additional states: Oregon, Colorado, New Jersey, Maryland, Pennsylvania, and Arkansas. This follows previous petitions in Ohio, Connecticut, Illinois, and New Mexico. Illinois and Connecticut have given preliminary approval, but formal adoption is pending. Ohio rejected the petition, and New Mexico will review it in October.
Personal Testimonies and Research
Rebecca Andersson from Oregon has highlighted the benefits she experienced with cannabis, including enhanced sexual pleasure and connection. She aims to make these benefits accessible to others by advocating for FOD as a qualifying condition. Clinical sexologist Suzanne Mulvehill supports this, citing research indicating that cannabis can improve orgasm ease and satisfaction.
Scientific Support
Studies by Mulvehill and others suggest that cannabis can address FOD by improving orgasm ease and frequency. Amanda Moser, a Colorado-based sexologist, has also supported the petition with research showing that cannabis can close the “orgasm inequality gap” and enhance sexual experiences.
Clinical Insights
Nan Wise, a sex therapist, emphasizes that medical cannabis can be an effective treatment for FOD, potentially improving sexual function through various mechanisms such as mood enhancement and reduced anxiety. Research also indicates that lower doses of THC may be more effective for improving sexual function.
Efforts to add FOD to medical cannabis programs highlight both personal experiences and growing scientific support for cannabis’s role in enhancing sexual health.
